1 |
Sorkin, E. M., Clissold, S. P. and Brogden, R. N. : Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders. Drugs. 30, 182 (1985)
|
2 |
Gan, S. L., Moseley, M. A., Khosla, B., Augustijns, P. F., Bradshaw, T. P., Hendren, R. W. and Thakker, D. R. : CYP3ALike cytochrome P450-mediated metabolism and polarized efflux of cyclosporin A in Caco-2 cells: interaction between the two biochemical barriers to intestinal transport. Drug Metab. Dispos. 24, 344 (1996)
|
3 |
Ito, K., Kusuhara, H. and Sugiyama, Y. : Effects of intestinal CYP3A4 and P-glycoprotein on oral drug absorption theoretical approach. Pharm. Res. 16, 225 (1999)
|
4 |
Endo, T., Kimura, O. and Sakata, M. : Effects of P-glycoprotein inhibitors on cadmium accumulation in cultured renal epithelial cells, LLC-PK1, and OK. Toxicol. Appl. Pharmacol. 185, 166 (2002)
|
5 |
Dupuy, J., Larrieu, G., Sutra, J. F., Lespine A. and Alvinerie, M. : Enhancement of moxidectin bioavailability in lamb by a natural flavonoid: Quercetin. Vet. Parasitol. 112, 337 (2003)
DOI
ScienceOn
|
6 |
Zhang, S. and Morris, M. E. : Effects of the flavonoids biochanin A, morin,phloretin, and silymarin on P-glycoproteinmediated transport. J. Pharmacol Exp. Ther. 304, 1258 (2003)
DOI
ScienceOn
|
7 |
Hodek, P., Trefil, P.and Stiborova, M. : Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450. Chem. Biol. Interact. 139, 1 (2002)
|
8 |
Iribarne, C., Dreano, L. G., Bardou, J. F., Menez, G. and Berthou, F. : Interaction of methadone with substrates of human hepatic cytochrome P450 3A4. Toxicology 117, 13 (1997)
|
9 |
Watkins, P. B. : The barrier function of CYP3A4 and Pglycoprotein in the small bowel. Adv. Drug Deliv. Rev. 27, 161 (1996)
|
10 |
Walter, D. G., Gruchy, B. S., Renwick, A. G. and George, C. F. : The first pass metabolism of nifedipine in man. Br. J. Clin. Pharmacol. 18, 951 (1984)
|
11 |
Kolars, J. C., Schmiedlin-Ren, P., Dobbins 3rd, W. O., Schuetz, J., Wrighton S. A. and Watkins, P. B. : Heterogeneity of cytochrome P450IIIA expression in rat gut epithelia. Gastroenterology 102, 1186 (1992)
|
12 |
Wacher, V. H., Silverman, J. A., Zhang Y. and Benet, L. Z. : Role of P-glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics. J. Pharm. Sci. 87, 1322 (1998)
|
13 |
Nijveldt, R. J., van Nood, E., van Hoorn, D. E. C., Boelens, P. G. van Norren, K. and van Leeuwen, P. A. M. : Flavonoids: A review of probable mechanisms of action and potential applications. Am. J. Clin. Nutr. 74, 418 (2001)
|
14 |
Gottesman, M. M. and Pastan, I. : Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62, 385 (1993)
|
15 |
Van Asperen, J., Van Tellingen, O., Sparreboom, A., Schinkel, A. H., Borst, P., Nooijen W. J. and Beijnen, J. H. : Enhanced oral bilavailability of diltiazem in mice treated with the pglycoprotein blocker. Br. J. Cancer. 76, 1181 (1997)
|
16 |
Hodek, P., Trefil, P., and Stiborova, M. : Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450. Chem. Biol. Interact. 139, 1 (2002)
|
17 |
Buening, M. K., Chang, R. L., Huang, M. T., Fortner, J. G., Wood, A. W. and Conney, A. H. : Activation and inhibition of benzo(a)pyrene and aflatoxin B1 metabolism in human liver microsomes by naturally occurring flavonoids. Cancer Res. 41, 67 (1981)
|
18 |
Li, X., Yun, J. K. and Choi, J. S. : Effects of morin on the pharmacokinetics of etoposide in rats. Biopharm. Drug Dispos. 28, 151 (2007)
DOI
ScienceOn
|
19 |
Ford, J. M. : Modulators of multidrug resistance preclinical studies. Hematol. Oncol. Clin. N. Am. 9, 337 (1995)
|
20 |
Choi, J. S. and Han, H. K. : Pharmacokinetic interaction between diltiazem and morin, a flavonoid, in rats. Pharmacol. Res. 52, 386 (2005)
DOI
ScienceOn
|
21 |
Rocci, M. L. and Jusko, W. J. : LAGRAN program for area and moments in pharmacokinetic analysis. Computer Programs in Biomedicine. 16, 203 (1983)
|
22 |
Biedler, J. L. and Riehm, H. : Cellular resistance to actinomycin D in Chinese hamster cells in vitro: crossresistance, radioautographic, and cytogenetic studies. Cancer Res. 30, 1174 (1970)
|
23 |
Grundy, J. S., Kherani, R. and Foster, R. T. : Sensitive highperformance liquid chromatographic assay for nifedipine in human plasma utilizing ultraviolet detection. J. Chromatogr. B. Biomed. Appl. 654, 146 (1994)
|
24 |
Choi, J. S. and Han, H. K. : Enhanced oral exposure of diltiazem by the concomitant use of naringin in rats. Int. J. Pharm. 23, 122 (2005)
|
25 |
Raemsch, K. D. and Sommer, J. C. : Pharmacokinetics and metabolism of nifedipine. Hypertension. 5, 18 (1983)
|
26 |
Guengerich, F. P., Brian, W. R. and Iwasaki, M. : Oxidation of dihydropyridine calcium channel blockers and analogues by human liver cytochrome P-450 IIIA4. J. Med. Chem. 4, 1838 (1991)
|
27 |
Dixon, R. A. and Steele, C. : Flavonoids and isoflavonoids-gold mine for metabolic engineering. Trends Plant Sci. 4, 394 (1999)
|
28 |
Doostdar, H., Burke, M. D. and Mayer, R. T. : Bioflavonoids: Selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1. Toxicology 144, 31 (2000)
|
29 |
Gottesman, M. M. and Pastan, I. : Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62, 385 (1993)
|
30 |
Henry, P. D. : Comparative pharmacology of calcium antagonists: nifedipine, verapamil and diltiazem. Am. J. Cardiol. 46, 1047 (1980)
|
31 |
Watkins, P. B., Wrighton, S. A., Schuetz, E. G., Molowa D. T. and Guzelian, P. S. : Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man. J. Clin. Invest. 80, 1029 (1987)
|
32 |
Fruehauf, J. P. and Manetta, A. : Use of extreme drug resistance assay to evaluate mechanisms of resistance in ovarian cancer: Taxol resistance and MDR1 expression. Contrib. Gynecol. Obstet. 19, 39 (1994)
|
33 |
Zhang, S. and Morris, M. E. : Effects of the flavonoids biochanin A, morin, phloretin, and silymarin on P-glycoproteinmediated transport. J. Pharmacol. Exp. Ther. 304, 1258 (2003)
DOI
ScienceOn
|
34 |
Chaudhary, P. M. and Robinson, I. B. : Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell. 66, 85 (1991)
|
35 |
Ito, K., Kusuhara, H. and Sugiyama, Y. : Effects of intestinal CYP3A4 and P-glycoprotein on oral drug absorption-- theoretical approach. Pharm. Res. 16, 225 (1999)
|
36 |
Bardelmeijer, H. A., Beijnen, J. H., Brouwer, K. R., Rosing, H., Nooijen, W. J., Schellens, J. H. and van Tellingen, O. : Increased oral bioavailability of paclitaxel by GF120918 in mice through selective modulation of P-glycoprotein. Clin. Cancer Res. 6, 4416 (2000)
|
37 |
Hokama, N., Hobara, N., Sakai, M., Kameya, H., Ohshiro S. and Sakanashi, M. : Influence of nicardipine and nifedipine on plasma carvedilol disposition after oral administration in rats. J. Pharm. Pharmacol. 54, 821 (2002)
|